Annuska M Glas

7PUBLICATIONS
77CO-AUTHORS
Tumour immunologyCancer geneticsPredictive and prognostic markersGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 17, 2025
Immune Subtyping Identifies Patients With Hormone Receptor-Positive Early-Stage Breast Cancer Who Respond to Neoadjuvant Immunotherapy (IO): Results From Five IO Arms of the I-SPY2 Trial.

Denise M Wolf, Christina Yau, Michael Campbell

|Jul 21, 2023
Obesity-associated changes in molecular biology of primary breast cancer.

Ha-Linh Nguyen, Tatjana Geukens, Marion Maetens

|Aug 19, 2022
BluePrint breast cancer molecular subtyping recognizes single and dual subtype tumors with implications for therapeutic guidance.

Midas M Kuilman, Architha Ellappalayam, Andrei Barcaru

|Jan 21, 2022
Outcome of Patients With an Ultralow-Risk 70-Gene Signature in the MINDACT Trial.

Josephine M N Lopes Cardozo, Caroline A Drukker, Emiel J T Rutgers

|Dec 29, 2021
High concordance of 70-gene recurrence risk signature and 80-gene molecular subtyping signature between core needle biopsy and surgical resection specimens in early-stage breast cancer.

Jennifer A Crozier, Julie Barone, Pat Whitworth

|Jul 29, 2020
Controlling technical variation amongst 6693 patient microarrays of the randomized MINDACT trial.

Laurent Jacob, Anke Witteveen, Inès Beumer

Pageof 2

Frequent Collaborators

4 joint publications

Laura Van't Veer

3 joint publications

Fatima Cardoso

3 joint publications

Marjanka K Schmidt

2 joint publications

Martine Piccart